Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    06-October-2000      
Issue 176 Next Update - 14:00 UTC 08:00 EST    07-October-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article In Today's Vidyya
ACIP recommends that the Prevnar ® vaccine against pneumococcal disease be considered for all children aged 24--59 months.

Proceed To Article Preventing Pneumococcal Disease Among Infants And Young Children: Recommendations Of The Advisory Committee On Immunization Practices (ACIP)
In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine was licensed for use among infants and young children. CDC's Advisory Committee on Immunization Practices (ACIP) recommends that the vaccine be used for all children aged 2--23 months and for children aged 24--59 months who are at increased risk for pneumococcal disease. ACIP also recommends that the vaccine be considered for all other children aged 24--59 months. More...

Proceed To Article Information For Professionals - Pneumococcal Disease
Pneumococcal Disease causes wide-spread illness and death throughout the United States each year. Pneumococcal disease kills more people in the United States every year - 40,000 or more - than all other vaccine preventable diseases combined. More...

Proceed To Article NIH To Fund Research For Alternative Therapies For Cancer
The National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH) announced plans to establish two specialized centers to conduct basic and clinical research on complementary and alternative medicine (CAM) therapies for cancer. More...

Proceed To Article The Prostate Cancer Outcomes Study
The Prostate Cancer Outcomes Study (PCOS) was initiated in 1994 by researchers at the National Cancer Institute (NCI) to look at the impact that treatments for primary prostate cancer have on the quality of life of patients. More...

Proceed To Article

First Once-A-Month Birth Control Option For US Women Approved By FDA
The Pharmacia Corporation announced today that the U.S. Food and Drug Administration (FDA) approved Lunelle ® Monthly Contraceptive Injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension), the first and only once-a-month contraceptive option for women in the U.S. Lunelle, a combined hormonal injectable contraceptive method, has contraceptive benefits similar to the pill yet offers women the convenience of once-a-month dosing. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.